Adenovirus-mediated delivery of soluble ST2 attenuates ovalbumin-induced allergic asthma in mice

Clinical and Experimental Immunology

Volumn 170, Issue 1, 2012, Pages 1-9

  Yin, H ^a   Li, X Y ^b   Liu, T ^a   Yuan, B H ^a   Zhang, B B ^a   Hu, S L ^a   Gu, H B ^a   Jin, X B ^a   Zhu, J Y ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Adenoviral vector; Allergic inflammation; Eosinophils; Soluble ST2; Th2 cytokines

Indexed keywords

ADENOVIRUS VECTOR; ANTIALLERGIC AGENT; IMMUNOGLOBULIN E; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; ST2 PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; FEMALE; GENE OVEREXPRESSION; GENE TRANSFER; HISTOPATHOLOGY; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADENOVIRIDAE; ADMINISTRATION, INTRANASAL; ALLERGENS; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILS; FEMALE; GENETIC THERAPY; GENETIC VECTORS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKINS; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-1; RECOMBINANT FUSION PROTEINS; TH2 CELLS;

EID: 84865632852     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04629.x     Document Type: Article

References (39)

1. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17:255-81.
2. Humbles AA, Lloyd CM, McMillan SJ etal. A critical role for eosinophils in allergic airways remodeling. Science 2004; 305:1776-9.
3. Umetsu DT, DeKruyff RH. TH1 and TH2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 1997; 100:1-6.
4. Robinson DS, Hamid Q, Ying S etal. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
5. Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 1997; 186:1737-47.
6. Werenskiold AK, Hoffmann S, Klemenz R. Induction of a mitogen responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts. Mol Cell Biol 1989; 9:5207-14.
7. Trajkovic V, Sweet MJ, Xu D. T1/ST2-an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev 2004; 15:87-95.
8. Iwahana H, Yanagisawa K, Ito-Kosaka A etal. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem 1999; 264:397-406.
9. Tago K, Noda T, Hayakawa M etal. Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V. Biochem Biophys Res Commun 2001; 285:1377-83.
10. Oboki K, Ohno T, Kajiwara N, Saito H, Nakae S. IL-33 and IL-33 receptors in host defense and diseases. Allergol Int 2010; 59:143-60.
11. Sweet MJ, Leung BP, Kang D etal. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 2001; 166:6633-9.
12. Brunner M, Krenn C, Roth G etal. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intens Care Med 2004; 30:1468-73.
13. Shimpo M, Morrow DA, Weinberg EO etal. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 2004; 109:2186-90.
14. Leung BP, Xu D, Culshaw S, McInnes IB, Liew FY. A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J Immunol 2004; 173:145-50.
15. Fagundes CT, Amaral FA, Souza AL etal. ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. J Leukoc Biol 2007; 81:492-9.
16. Yin H, Huang BJ, Yang H etal. Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury. Biochem Biophys Res Commun 2006; 351:940-6.
17. Ramaprakash H, Shibata T, Duffy KE etal. Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model. Am J Pathol 2011; 179:104-15.
18. Matsuda A, Okayama Y, Terai N etal. The role of interleukin-33 in chronic allergic conjunctivitis. Invest Ophthalmol Vis Sci 2009; 50:4646-52.
19. Walzl G, Matthews S, Kendall S etal. Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J Exp Med 2001; 193:785-92.
20. Yin H, Li XY, Jin XB etal. IL-33 prolongs murine cardiac allograft survival through induction of TH2-type immune deviation. Transplantation 2010; 89:1189-97.
21. Yin H, Li XY, Yuan BH etal. Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice. Clin Exp Immunol 2011; 164:248-55.
22. Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 2009; 386:181-5.
23. Kearley J, Buckland KF, Mathie SA, Lloyd CM. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 2009; 179:772-81.
24. Xu B, Aoyama K, Kusumoto M etal. Lack of lymphoid chemokines CCL19 and CCL21 enhances allergic airway inflammation in mice. Int Immunol 2007; 19:775-84.
25. Gajewska BU, Swirski FK, Alvarez D etal. Temporal-spatial analysis of the immune response in a murine model of ovalbumin-induced airways inflammation. Am J Respir Cell Mol Biol 2001; 25:326-34.
26. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320:271-7.
27. Giri JG, Wells J, Dower SK etal. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J Immunol 1994; 153:5802-9.
28. Sato TA, Widmer MB, Finkelman FD etal. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J Immunol 1993; 150:2717-23.
29. Xu W, Presnell SR, Parrish-Novak J etal. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci USA 2001; 98:9511-6.
30. Hurst SM, Wilkinson TS, McLoughlin RM etal. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14:705-14.
31. Levine SJ. Molecular mechanisms of soluble cytokine receptor generation. J Biol Chem 2008; 283:14177-81.
32. Schmitz J, Owyang A, Oldham E etal. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2- associated cytokines. Immunity 2005; 23:479-90.
33. Hayakawa H, Hayakawa M, Kume A, Tominaga SI. Soluble ST2 blocks IL-33 signaling in allergic airway inflammation. J Biol Chem 2007; 36:26369-80.
34. Oshikawa K, Kuroiwa K, Tago K etal. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001; 164:277-81.
35. Suzuki M, Suzuki S, Yamamoto N etal. Immune responses against replication-deficient adenovirus inhibit ovalbumin-specific allergic reactions in mice. Hum Gene Ther 2000; 11:827-38.
36. Wang CC, Fu CL, Yang YH etal. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma. Gene Ther 2006; 13:1414-21.
37. Behera AK, Kumar M, Lockey RF, Mohapatra SS. Adenovirus mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum Gene Ther 2002; 13:1697-709.
38. Coyle AJ, Lloyd C, Tian J etal. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999; 190:895-902.
39. Kurowska-Stolarska M, Stolarski B, Kewin P etal. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009; 183:6469-77.